Maxinovel Pty., Ltd. Report issue

For profit Phase 1 Phase 2
Founded: Beverly Hills Australia (2017)

Organization Overview

First Clinical Trial
2018
NCT03412292
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Maxinovel Pty., Ltd.